Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter study of MDMA-assisted psychotherapy for PTSD related to childhood sexual trauma versus adult trauma
MOH_2024-01-10_013175Phase 3Not yet recruiting
- Sponsor
- ד"ר ערן הראל
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of midomafetamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by ד"ר ערן הראל. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on MOH_2024-01-10_013175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-01-10_013175.